ESPAC-3(v2): A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma

  1. Lookup NU author(s)
  2. Dr Deborah Stocken
Author(s)Neoptolemos J, Buchler M, Stocken DD, Ghaneh P, Smith D, Bassi C, Moore M, Cunningham D, Dervenis C, Goldstein D
Publication type Conference Proceedings (inc. Abstract)
Conference Name45th Annual Meeting of the American Society of Clinical Oncology
Conference LocationOrlando, Florida
Year of Conference2009
Source Publication Date29 May-2 June 2009
Volume27 (15, s)
Series TitleJournal of Clinical Oncology
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherAmerican Society of Clinical Oncology
ActionsLink to this publication
Library holdingsSearch Newcastle University Library for this item